📢 Save the date! 🔷We are pleased to announce that IOMED will be present at the 2nd annual edition of the Clinical Outsourcing Group Europe 📆November 12th-13th 📍Novotel Amsterdam City, The Netherlands 🤝COG Europe brings together senior decision-makers from the four corners of Europe to hear from thought leaders from the biopharmaceutical industry, regulatory bodies and academia, along with a group of the most trusted and innovative solution providers serving the European market. ☑️The aim of the event is to improve clinical trial processes, enhance patient participation and address the business and partnership aspects of clinical research. https://lnkd.in/ep-ADhK9 #COGEUROPE #clinicalresearch #outsourcing #biopharma #digitalhealth #artificialintelligence #AI #clinicaltrial #patientrecruitment
IOMED
Desarrollo de software
Barcelona, Cataluña / Catalunya 15.151 seguidores
Empowering Healthcare Data
Sobre nosotros
Our Healthcare Data Activation technology leverages the power of Artificial Intelligence to unlock healthcare data from hospitals' data sources. We activate data from both structured and unstructured sources, including human-written records, thanks to our Natural Language Processing System. All data is standardizend into OMOP Common Data Model , and never leaves hospitals' in-house systems, thanks to our Federated Data Model , enabling its comprehensive understanding for healthcare information while maintaining data protection and security.
- Sitio web
-
https://iomed.health/
Enlace externo para IOMED
- Sector
- Desarrollo de software
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Barcelona, Cataluña / Catalunya
- Tipo
- De financiación privada
- Fundación
- 2016
- Especialidades
- Datos clínicos , Estructuración de datos, Inteligencia Artificial, Historia clínica, EHR, Health IT, Deep Learning, API , Software, HCE y Natural Language Processing
Ubicaciones
-
Principal
Carrer de Sant Antoni Maria Claret, 167
Recinte Modernista Sant Pau, Edificio Sant Manel
Barcelona, Cataluña / Catalunya 08025, ES
Empleados en IOMED
Actualizaciones
-
Amazing work, team! 🎉 This demonstrates how innovation and collaboration can transform clinical research. It’s inspiring to see the talent and dedication of Gabriel Maeztu, Miguel-Angel Mayer , Mónica Arrúe Gabaráin, Mariona Forcada Romeu, María Quijada López and Paula Chocrón. Let’s keep pushing the boundaries of digital transformation in healthcare! OHDSI (Observational Health Data Sciences & Informatics)
Integrating NLP-derived results in the OMOP CDM #OHDSISocialShowcase #JoinTheJourney Lead: Gabriel Maeztu Team: Mónica Arrúe Gabaráin, Mariona Forcada Romeu, María Quijada, Paula Chocrón, Miguel-Angel Mayer https://loom.ly/2LUuP5Q
Integrating NLP-derived results in the OMOP CDM
ohdsi-europe.org
-
IOMED ha compartido esto
💹 While global #investment in #DigitalHealth experienced a decline in 2023, #Catalonia defied the trend by not only increasing by 61% compared to the previous year but also approaching its historical peak in 2021, reaching €64 M! This notable growth was primarily attributed to three key operations: Qida (home-care) (💰 €18 M), IOMED (💰 €10 M), and Top Doctors (💰 €8 M). 🥇 The #biotech subsector is the one that attracted the most funding in the #BioRegionCatalonia in 2023, surpassing 110M€! Notable operations included those of SOM Biotech (💰 €17 M), Nuage Therapeutics (💰 €12 M), and Oryzon Genomics SA (💰 €8 M). Likewise, the #medtech subsector, although facing a decline, has successfully rebounded to #investment levels seen before 2021. The three most significant operations in this subsector were INBRAIN Neuroelectronics (💰 €20 M), ADmit Therapeutics (💰 €5.4 M), and deepull Diagnostics (💰 €4 M). 📋 More data in the #BioRegionReport: https://report.biocat.cat/ Promoted by: Biocat, BioRegion of Catalonia With the support of: Amgen, Almirall, AstraZeneca, Cuatrecasas, ESTEVE, and Sanofi. In collaboration with: Catalonia.Health (CataloniaBio & HealthTech), ACCIÓ, Farmaindustria and Fenin, Federación Española de Empresas de Tecnología Sanitaria.
-
IOMED ha compartido esto
Standardizing European sarcoma registry data to the OMOP Common Data Model: the retroperitoneal sarcoma use case #OHDSISocialShowcase #JoinTheJourney Lead: Peter Prinsen Team: Paolo Lasalvia, Roberto Lillini, Vittoria Ramella, Anna Alloni, Joanna Szkandera, Espen Enerly, Maaike van Swieten, PhD, Siri Larønningen, Julien Bollard, Audrey Pons, Thomas Gaudin, Claire Chemin-Airiau, Alric SANS, Jean-Yves Blay, Arnaud Malfilatre, Danielle Newby, Gijs Geleijnse, Annalisa Trama https://loom.ly/APLTm7s
Standardizing European sarcoma registry data to the OMOP Common Data Model: the retroperitoneal sarcoma use case
ohdsi-europe.org
-
🌍 IOMED Contributes to Shaping the European Health Data Space (EHDS) We’re proud to share that IOMED is playing a pivotal role in advancing the European Health Data Space (EHDS) initiative! 🚀 By collaborating with key stakeholders across Europe, we’re helping to create a unified framework for health data, ensuring secure and efficient data sharing across the continent. Our contributions are centered around leveraging real-world data (RWD) and artificial intelligence (AI) to enhance data interoperability and accessibility, driving forward innovation in healthcare. This is a crucial step toward a more connected and data-driven healthcare system in Europe. Together, we’re paving the way for a future where health data is harnessed to improve patient outcomes and accelerate medical research. 💪 #IOMED #HealthData #DigitalHealth #Interoperability #EHDS #HealthInnovation #GDPR #ClinicalResearch #Healthcare #EuropeanHealthDataSpace #OMOP
IOMED contributes to the European Health Data Space goals
iomed.health
-
🙌 We are delighted to announce that Mats Sundgren, PhD, MSc, a recognized expert in Health Data Strategy, has joined IOMED as our new Scientific Advisor. 🚀With an impressive 37 year career in the pharmaceutical sector, Mats has significantly impacted areas such as Discovery, Development, Manufacturing, IT R&D, Patents, Clinical Science and Data Science and AI. His pioneering leadership has continuously advanced technological progress in healthcare. 🗣️“IOMED's cutting-edge technology has the potential to revolutionize healthcare, making it more efficient and accessible. By leveraging the advanced capabilities of #NLP and the #OMOP common data model, IOMED sets itself apart in the industry, offering exceptional insights and driving important advances in personalized medicine and clinical research. I am delighted to bring my experience and expertise to help achieve the goals set by the European Health Data Space and contribute to the development of a secure and interoperable data environment,” says Mats. 👋Let's welcome Mats Sundgren to IOMED. https://lnkd.in/dJdXRs-C #HealthcareInnovation #DataScience #HealthDataStrategy #AI #IOMED #EHDS
Mats Sundgren, a distinguished expert in Health Data Strategy, joins IOMED as Scientific Advisor
-
💥IOMED has been awarded the European Union Seal of Excellence for meeting quality requirements. ☑️This achievement reflects the hard work and dedication of our team and our ability to stand out in an increasingly competitive business environment. 🇪🇺With this certificate, the European Commission, renowned for its rigorous evaluation process, officially endorses the quality and uniqueness of our initiatives. 🙌 At IOMED, we continue to raise the standards of excellence in innovation, committing ourselves to promoting projects that will set the standard for innovation in the future. https://lnkd.in/dK-Yd7Qn #IOMED #SealofExcellence #NLP #NaturalLanguageProcessing #AI #ArtificialIntelligence #ObservationalStudies #HospitalData #HealthCareInnovation
IOMED receives the European Union Seal of Excellence
iomed.health
-
🎥"IOMED's technology will allow us to participate in multicenter studies on big data and artificial intelligence", explains Dr. Sílvia Mateu, Research Coordinator of the Fundació Puigvert after the agreement with #IOMED. ➡️The Puigvert Foundation already has two possible projects in mind in which to incorporate this technology. One in the field of uro-oncology and the other in the field of hereditary kidney diseases. https://lnkd.in/eFn663vQ #NaturalLanguageProccessing #NLP #ArtificialIntelligence #bigdata
IOMED - Puigvert Fundation
https://www.youtube.com/
-
🚀 Revolutionizing Clinical Research with IOMED At IOMED, we’re leading the charge in transforming clinical research. Our AI-powered Data Space Platform 💻 rapidly structures and standardizes medical data, unlocking the full potential of real-world data (RWD) for clinical trials. With advanced natural language processing (NLP) 🧠, we convert free-text clinical notes into actionable data, driving faster, more cost-effective trials and accelerating the path to new treatments. Join us at the forefront of innovation—where AI meets healthcare for better outcomes. 🌟 #ClinicalResearch #AI #Innovation #RWD #IOMED
Transforming Clinical Research with IOMED: Depth and Efficiency in Real-World Data (RWD)
iomed.health
-
IOMED ha compartido esto
Fondo Bolsa Social , gestionado por Afi Inversiones Globales, SGIIC, ha publicado su Informe de Impacto 2023. Ha sido el año con más inversiones desde su fundación, tanto en número de startups como en capital invertido. En 2023 se incorporaron IOMED, NEWE , Eurid, ADAION y toddl.co. Algunos de los resultados de la cartera: 💧 Casi 5 mil millones de #agua ahorrados 🌫️ Más de 18.000 toneladas de #Co2 evitadas 📚 Más de 330.000 estudiantes impactados 👤 Más de 50.000 personas atendidas. Informe completo ➡ https://lnkd.in/dZnM2J2g
📗 Presentamos muy ilusionados nuestro Informe de Impacto 2023 🌍 En él explicamos nuestra Teoría del Cambio, el impacto de las startups en las que hemos invertido, y también compartimos cómo medimos y gestionamos el impacto de nuestra cartera, incluyendo los criterios de ASG, con el objetivo de maximizar su impacto positivo. 💫 En un entorno donde las soluciones a problemas sociales y ambientales son cada vez más urgentes, desde el Fondo Bolsa Social queremos actuar como un catalizador de cambio. Tenemos un enfoque hacia el cambio fundamentado en una visión pragmática. Reconocemos la urgencia de los desafíos actuales como la crisis climática y las crecientes desigualdades sociales, por lo que nuestra estrategia está diseñada para impulsar una transformación hacia un modelo de sociedad que priorice el bienestar humano y la sostenibilidad del planeta. https://lnkd.in/dSwXqSZF
INFORME DE IMPACTO FONDO BOLSA SOCIAL 2023
bolsasocial.fund
Páginas similares
Buscar empleos
Financiación
Última ronda
Serie A10.753.208,00 US$